NASDAQ:IOSP - Innospec Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$81.55 -0.95 (-1.15 %)
(As of 07/22/2018 06:45 AM ET)
Previous Close$81.55
Today's Range$81.3750 - $82.30
52-Week Range$54.10 - $83.20
Volume47,422 shs
Average Volume85,867 shs
Market Capitalization$1.99 billion
P/E Ratio17.54
Dividend Yield2.16%
Beta1.06
Innospec logoInnospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and mining markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in an environmental remediation business that manages the cleanup of redundant TEL plants. The company serves oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, formulators of personal care and home care, agrochemical and mining formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554

Debt

Debt-to-Equity Ratio0.24
Current Ratio2.13
Quick Ratio1.28

Price-To-Earnings

Trailing P/E Ratio17.54
Forward P/E Ratio18.12
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.31 billion
Price / Sales1.52
Cash Flow$6.8243 per share
Price / Cash11.95
Book Value$32.91 per share
Price / Book2.48

Profitability

EPS (Most Recent Fiscal Year)$4.66
Net Income$61.80 million
Net Margins4.86%
Return on Equity14.91%
Return on Assets8.37%

Miscellaneous

Employees1,900
Outstanding Shares24,400,000
Market Cap$1,990.06

Innospec (NASDAQ:IOSP) Frequently Asked Questions

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec announced a semiannual dividend on Wednesday, May 9th. Shareholders of record on Monday, May 21st will be given a dividend of $0.44 per share on Thursday, May 31st. This represents a yield of 1.18%. The ex-dividend date is Friday, May 18th. This is an increase from Innospec's previous semiannual dividend of $0.39. View Innospec's Dividend History.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) announced its quarterly earnings results on Tuesday, May, 8th. The specialty chemicals company reported $1.02 EPS for the quarter, beating the Zacks' consensus estimate of $0.91 by $0.11. The specialty chemicals company earned $360.70 million during the quarter, compared to analyst estimates of $308.90 million. Innospec had a return on equity of 14.91% and a net margin of 4.86%. The company's revenue was up 22.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.00 EPS. View Innospec's Earnings History.

When is Innospec's next earnings date?

Innospec is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Innospec.

What price target have analysts set for IOSP?

3 equities research analysts have issued 1 year target prices for Innospec's shares. Their forecasts range from $65.00 to $86.00. On average, they anticipate Innospec's share price to reach $75.50 in the next year. This suggests that the stock has a possible downside of 7.4%. View Analyst Ratings for Innospec.

What is the consensus analysts' recommendation for Innospec?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Innospec's key competitors?

Who are Innospec's key executives?

Innospec's management team includes the folowing people:
  • Mr. Patrick S. Williams, Pres, CEO & Director (Age 53)
  • Mr. Ian P. Cleminson, Exec. VP & CFO (Age 52)
  • Dr. Philip J. Boon, COO & Exec. VP (Age 59)
  • Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 69)
  • Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 59)

Has Innospec been receiving favorable news coverage?

Media coverage about IOSP stock has trended somewhat positive recently, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Innospec earned a news sentiment score of 0.15 on Accern's scale. They also gave headlines about the specialty chemicals company an impact score of 47.71 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Innospec's major shareholders?

Innospec's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Kirr Marbach & Co. LLC IN (0.75%), ZWJ Investment Counsel Inc. (0.25%), Creative Planning (0.06%), Municipal Employees Retirement System of Michigan (0.03%), Xact Kapitalforvaltning AB (0.02%) and Capital One National Association (0.02%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Joachim Roeser, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.

Which major investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Kirr Marbach & Co. LLC IN, Municipal Employees Retirement System of Michigan and ZWJ Investment Counsel Inc.. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.

Which major investors are buying Innospec stock?

IOSP stock was bought by a variety of institutional investors in the last quarter, including Creative Planning, Capital One National Association, First Citizens Bank & Trust Co. and Xact Kapitalforvaltning AB. View Insider Buying and Selling for Innospec.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $81.55.

How big of a company is Innospec?

Innospec has a market capitalization of $1.99 billion and generates $1.31 billion in revenue each year. The specialty chemicals company earns $61.80 million in net income (profit) each year or $4.66 on an earnings per share basis. Innospec employs 1,900 workers across the globe.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]


MarketBeat Community Rating for Innospec (NASDAQ IOSP)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  144 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  288
MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.